[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.197.142.219. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Medical News & Perspectives
June 10, 1998

Guidelines for Treating Dementia-Associated Agitation

Author Affiliations
 

Not Available

Not Available

JAMA. 1998;279(22):1770. doi:10.1001/jama.279.22.1770-JMN0610-3-1

SEVERE AGITATION can be much more disturbing to older persons with dementia and their caregivers than the more commonly addressed problems of loss of cognition and memory. A new set of guidelines addresses the disruptive, often harmful, behaviors that may be associated with Alzheimer disease and the other forms of dementia that affect some 4 million Americans older than 65 years.

The Expert Consensus Guidelines for the Treatment of Agitation in Older Persons With Dementia were developed under the direction of investigators at Columbia University College of Physicians and Surgeons, Cornell University Medical College, and New York University School of Medicine, all in New York, NY, and Duke University School of Medicine, in Durham, NC. Their preparation was supported by unrestricted educational grants from Janssen Pharmaceuticals, Bristol-Myers Squibb Company, and Abbott Laboratories.

First Page Preview View Large
First page PDF preview
First page PDF preview
×